JRI (Nuveen Real Assetome and Growth Fund) Common Stock: $0.27 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JRI Nuveen Real Asset Income and Growth Fund JRI
48 GF Score
Price $12.94
GF Value $23.36
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Nuveen Real Assetome and Growth Fund Common Stock?

Nuveen Real Assetome and Growth Fund JRI -0.46% 48 Common Stock is $0.27 Mil as of Dec. 2025. GuruFocus rates JRI with a GF Score™ of 48/100 and a GF Value™ of $23.36 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Nuveen Real Assetome and Growth Fund's quarterly common stock stayed the same from Dec. 2024 ($0.27 Mil) to Jun. 2025 ($0.27 Mil) and stayed the same from Jun. 2025 ($0.27 Mil) to Dec. 2025 ($0.27 Mil).

Nuveen Real Assetome and Growth Fund's annual common stock stayed the same from Dec. 2023 ($0.27 Mil) to Dec. 2024 ($0.27 Mil) and stayed the same from Dec. 2024 ($0.27 Mil) to Dec. 2025 ($0.27 Mil).

Nuveen Real Assetome and Growth Fund Common Stock Historical Data

* Premium members only.

The historical data trend for Nuveen Real Assetome and Growth Fund's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuveen Real Assetome and Growth Fund Common Stock Chart

Nuveen Real Assetome and Growth Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only 0.28 0.28 0.27 0.27 0.27

Nuveen Real Assetome and Growth Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.27 0.27 0.27 0.27
JRI
48GF Score
Nuveen Real Asset Income and Growth Fund JRI
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuveen Real Assetome and Growth Fund Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.27 Mil mean?
Nuveen Real Assetome and Growth Fund (JRI) has a Common Stock of $0.27 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nuveen Real Assetome and Growth Fund and its competitors.
Is Nuveen Real Assetome and Growth Fund's Common Stock too high?
Nuveen Real Assetome and Growth Fund's current Common Stock is $0.27 Mil. Overall, Nuveen Real Assetome and Growth Fund has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nuveen Real Assetome and Growth Fund's Common Stock compare to HIX and MIY?
Nuveen Real Assetome and Growth Fund's Common Stock of $0.27 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Asset Management company?
A good Common Stock depends on the Asset Management industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nuveen Real Assetome and Growth Fund and its competitors. Nuveen Real Assetome and Growth Fund's current Common Stock is $0.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen Real Assetome and Growth Fund stock overvalued right now?
Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund (JRI) is currently considered Significantly Undervalued. The stock's GF Value™ is $23.36, compared to a current price of $12.94 — trading 44.6% below its estimated fair value. The current Common Stock is $0.27 Mil. Nuveen Real Assetome and Growth Fund's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nuveen Real Assetome and Growth Fund (JRI), the current Common Stock is $0.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nuveen Real Assetome and Growth Fund (JRI) Overvalued in 2026?

Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund stock appears to be undervalued. The current stock price of $12.94 is trading 44.6% below its estimated GF Value™ of $23.36. GuruFocus considers Nuveen Real Assetome and Growth Fund to be Significantly Undervalued.

Key valuation signals for JRI:

  • Common Stock: $0.27 Mil
  • GF Value™: $23.36 vs. price of $12.94 (44.6% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the JRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nuveen Real Assetome and Growth Fund Business Description

Address 333 West Wacker Drive, Chicago, IL, USA, 60606
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
48GF Score

Get the complete analysis for JRI

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.94
Price
$23.36
GF Value